Table 5.
Variable | Beta estimate | P value | 95% CI (lower, upper) |
---|---|---|---|
Outcome = NPT-14 baseline | |||
Age | 0.000525 | 0.9969 | −0.2739, 0.2750 |
Female sex | −3.2748 | 0.2562 | −9.0318, 2.4822 |
CSF CD4+ | 0.002396 | 0.0173* | 0.000449, 0.004344 |
CSF CD8+ | −0.00029 | 0.5289 | −0.00121, 0.000632 |
CSF percentage HLA-DR+ CD8+ T cells | 0.07469 | 0.4514 | −0.1243, 0.2737 |
CSF percentage non-classical monocytes | 5.1778 | 0.5724 | −13.2536, 23.6092 |
log CSF HIV RNA | −1.5744 | 0.2511 | −4.3115, 1.1627 |
Outcome = NFL baseline | |||
Age | 234.30 | 0.2999 | −217.49, 686.09 |
Female sex | −4168.45 | 0.3783 | −13,646, 5309.30 |
CSF CD4+ | 0.1884 | 0.9058 | −3.0178, 3.3946 |
CSF CD8+ | −0.9800 | 0.1977 | −2.4946, 0.5345 |
CSF percentage HLA-DR+ CD8+ T cells | −198.33 | 0.2274 | −525.90, 129.23 |
CSF percentage non-classical monocytes | −1858.89 | 0.9018 | −32,202, 28,485 |
log CSF HIV RNA | 5755.84 | 0.0137* | 1249.69, 10,262 |
Outcome = NPT-14 change | |||
Age | 0.1762 | 0.1700 | −0.08325, 0.4357 |
Female sex | −6.4043 | 0.0134* | −11.3011, −1.5075 |
CSF CD4+ baseline | −0.00085 | 0.1578 | −0.00207, 0.000364 |
CSF CD8+ baseline | 0.000226 | 0.4158 | −0.00035, 0.000799 |
CSF % HLA-DR+ CD8+ T cells baseline | −0.2511 | 0.0056* | −0.4181, −0.08417 |
CSF % non-classical monocytes baseline | −2.7496 | 0.7314 | −19.3755, 13.8764 |
log CSF HIV RNA baseline | −0.4862 | 0.6630 | −2.7990, 1.8266 |
Outcome = NFL change | |||
Age | −192.91 | 0.6912 | −1199.98, 814.17 |
Female sex | 6695.85 | 0.4674 | −12,308, 25,700 |
CSF CD4+ baseline | 0.4785 | 0.8329 | −4.2347, 5.1917 |
CSF CD8+ baseline | 0.9218 | 0.3938 | −1.3009, 3.1444 |
CSF % HLA-DR+ CD8+ T cells baseline | 339.36 | 0.2845 | −308.54, 987.27 |
CSF % non-classical monocytes baseline | 4890.66 | 0.8748 | −59,632, 69,414 |
log CSF HIV RNA baseline | −8559.65 | 0.0603 | −17,535, 415.86 |
P values < .05 are denoted by asterisk.